Harrow (HROW) Competitors

Harrow (NASDAQ:HROW) and Zai Lab (NASDAQ:ZLAB) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, media sentiment, risk, earnings, analyst recommendations, dividends, community ranking and institutional ownership.

Does the MarketBeat Community prefer HROW or ZLAB?

Zai Lab received 138 more outperform votes than Harrow when rated by MarketBeat users. Likewise, 64.53% of users gave Zai Lab an outperform vote while only 59.62% of users gave Harrow an outperform vote.

Company	Underperform	Outperform
Harrow	Outperform Votes 93 59.62%	Underperform Votes 63 40.38%
Zai Lab	Outperform Votes 231 64.53%	Underperform Votes 127 35.47%

Which has more risk & volatility, HROW or ZLAB?

Harrow has a beta of 0.46, meaning that its share price is 54% less volatile than the S&P 500. Comparatively, Zai Lab has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500.

Which has preferable earnings & valuation, HROW or ZLAB?

Harrow has higher earnings, but lower revenue than Zai Lab. Harrow is trading at a lower price-to-earnings ratio than Zai Lab, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Harrow	$199.61M	4.28	-$24.41M	-$0.44	-54.52
Zai Lab	$398.99M	7.92	-$334.62M	-$2.59	-11.14

Do institutionals & insiders have more ownership in HROW or ZLAB?

72.8% of Harrow shares are held by institutional investors. Comparatively, 41.7% of Zai Lab shares are held by institutional investors. 13.7% of Harrow shares are held by company insiders. Comparatively, 13.9% of Zai Lab shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Does the media favor HROW or ZLAB?

In the previous week, Harrow and Harrow both had 10 articles in the media. Harrow's average media sentiment score of 1.30 beat Zai Lab's score of 0.99 indicating that Harrow is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Harrow	7 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zai Lab	9 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Is HROW or ZLAB more profitable?

Harrow has a net margin of -19.75% compared to Zai Lab's net margin of -76.14%. Zai Lab's return on equity of -36.97% beat Harrow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Harrow	-19.75%	-45.57%	-8.87%
Zai Lab	-76.14%	-36.97%	-27.10%

Do analysts rate HROW or ZLAB?

Harrow currently has a consensus price target of $60.50, indicating a potential upside of 152.19%. Zai Lab has a consensus price target of $47.37, indicating a potential upside of 64.24%. Given Harrow's stronger consensus rating and higher possible upside, research analysts clearly believe Harrow is more favorable than Zai Lab.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Harrow	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
Zai Lab	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Summary

Harrow beats Zai Lab on 9 of the 17 factors compared between the two stocks.